Malignant Gliomas in Adults

The second edition of this well-received volume has been revised and updated to reflect the advances in pathological classification and molecular epidemiology of diffuse low-grade gliomas (DLGG) in adults and offers an updated review on individualized therapies. This book presents the latest research pertaining to the diagnosis, genetics, therapy and management of DLGGs.

The second edition of this well-received volume has been revised and updated to reflect the advances in pathological classification and molecular epidemiology of diffuse low-grade gliomas (DLGG) in adults and offers an updated review on individualized therapies. This book presents the latest research pertaining to the diagnosis, genetics, therapy and management of DLGGs.

The second edition of this well-received volume has been revised and updated to reflect the advances in pathological classification and molecular epidemiology of diffuse low-grade gliomas (DLGG) in adults and offers an updated review on individualized therapies. This book presents the latest research pertaining to the diagnosis, genetics, therapy and management of DLGGs.

If you have recently been diagnosed with type 2 diabetes, you will need to make some changes in your life that seem unwelcome and unnecessary. There is a wide range of treatments for this form of diabetes, from dietary adjustment and increased activity through to tablets and the use of insulin. Each new stage can lead to anxiety and a feeling that you are not in control.

This book provides the most current advancements in the medical care of glioma patients, accompanied by clinical cases. Clinical implementations of the new multilayered integrated diagnosis of gliomas according to WHO CNS5 are also demonstrated here. New adjuvant therapies, such as chemotherapy/targeted therapy, immunotherapy, and physiotherapy, are discussed in the book. The book also covers the applications of genomics and epigenomics of gliomas in clinical practice. In essence, this book shows the management of gliomas with new treatment modalities, which can prolong the overall survival time of patients fighting glioma.

This book provides the most current advancements in the medical care of glioma patients, accompanied by clinical cases. Clinical implementations of the new multilayered integrated diagnosis of gliomas according to WHO CNS5 are also demonstrated here. New adjuvant therapies, such as chemotherapy/targeted therapy, immunotherapy, and physiotherapy, are discussed in the book. The book also covers the applications of genomics and epigenomics of gliomas in clinical practice. In essence, this book shows the management of gliomas with new treatment modalities, which can prolong the overall survival time of patients fighting glioma.